Novartis revenue increased from $48.5 billion in 2016 to $49.1 billion in 2017, a 1.2% increase.

Annual Revenue ($)

Novartis revenue was $49.11 b in FY, 2017 which is a 1.2% year over year increase from the previous period.

FY, 2015FY, 2016FY, 2017
Revenue$49.41 b$48.52 b$49.11 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Novartis revenue breakdown by business segment: 67.5% from Innovative Medicines, 20.4% from Sandoz and 12.1% from Alcon

Novartis revenue breakdown by geographic segment: 6.4% from Germany, 36.7% from United States, 6.4% from Japan and 50.5% from Other

FY, 2017FY, 2016FY, 2015
Innovative Medicines33.03 b32.56 b33.35 b
Sandoz10.06 b10.14 b10.07 b
Alcon6.02 b5.81 b6 b
FY, 2017FY, 2016FY, 2015
Germany3.69 b3.63 b3.16 b
United Kingdom1.16 b1.18 b1.28 b
France2.49 b2.39 b2.27 b
Other20.82 b20.10 b20.59 b
United States16.94 b17.12 b18.08 b
Switzerland 836 m830 m774 m
Japan 3.18 b3.27 b3.16 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.